B. Riley lowered the firm's price target on EverQuote to $30 from $36 and keeps a Buy rating on the shares. EverQuote reported "strong" Q4 results, with revenue and adjusted EBITDA exceeding guidance and consensus, with upside driven by strong auto insurance performance, the analyst tells investors in a research note. Risk/reward heavily skews to the positive considering EverQuote's durable growth, sustained margin expansion, robust free cash flow generation, pristine balance sheet, and the seemingly misplaced fears around AI disruption, the firm says.
